Rhabdomyolysis following Cardiopulmonary Bypass and Treatment with Enoximone in a Patient Susceptible to Malignant Hyperthermia
- 1 February 2001
- journal article
- case report
- Published by Wolters Kluwer Health in Anesthesiology
- Vol. 94 (2) , 355-357
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Effects of the phosphodiesterase-III inhibitor enoximone on skeletal muscle specimens from malignant hyperthermia susceptible patientsJournal of Clinical Anesthesia, 2000
- 4-Chloro-m-cresol is a Trigger of Malignant Hyperthermia in Susceptible SwineAnesthesiology, 1999
- Diagnostik der Disposition zur malignen Hyperthermie durch einenin vitroKontrakturtest mit dem Phosphodiesterase-III-Hemmstoff EnoximonAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 1998
- In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: Results of testing patients surviving fulminant MH and unrelated low‐risk subjectsActa Anaesthesiologica Scandinavica, 1997
- In Vitro Diagnosis of Malignant Hyperthermia Susceptibility with Ryanodine-Induced Contractures in Human Skeletal MusclesAnesthesia & Analgesia, 1996
- The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermiaHuman Molecular Genetics, 1994
- Phosphorylation of the porcine skeletal and cardiac muscle sarcoplasmic reticulum ryanodine receptorBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1993
- Phosphodiesterase inhibitors and the cardiac sarcoplasmic reticulum calcium release channel: differential effects of milrinone and enoximoneCardiovascular Research, 1991
- CYCLIC AMP IN NORMAL AND MALIGNANT HYPERPYREXIA SUSCEPTIBLE INDIVIDUALS FOLLOWING EXERCISE *British Journal of Anaesthesia, 1984
- High skeletal muscle adenylate cyclase in malignant hyperthermia.Journal of Clinical Investigation, 1981